CalciMedica, Inc. Common Stock (CALC) Live Share Price, Invest From India

CalciMedica, Inc. Common Stock Stock Performance

as on May 2, 2026 at 6:59 am IST

Day's Low
Day's High
$0.57
Day's Price Range
$0.62
$0.58
1.72%
Downside
6.90%
Upside
52 Week's Low
52 Week's High
$0.46
52-Week Price Range
$7.20
$0.58
20.59%
Downside
1141.38%
Upside

CalciMedica, Inc. Common Stock share price movements today

Previous Close: $0.59
Open: $0.60
Volume: 2.3M
Day's Low - High: $0.57 - $0.62
52 Week Low - High: $0.46 - $7.20

CalciMedica, Inc. Common Stock Historical Returns

1 Month Return: + 0.62 %
3 Month Return: -12.15 %
1 Year Return: -66.37 %
3 Year Return: -84.51 %
5 Year Return: 0 %

CalciMedica, Inc. Common Stock Stock Fundamentals & Key Indicators

Check CalciMedica, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.3M

EPS (TTM)

-1.2333

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-23.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-761.03%

CalciMedica, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CalciMedica, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
CalciMedica, Inc. Common Stock	BUY	$9.3M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Stock Returns calculator for CalciMedica, Inc. Common Stock Stock including INR - Dollar returns

The CalciMedica, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

CalciMedica, Inc. Common Stock investment value today

Current value as on today

₹37,214

Returns

-₹62,786

(-62.79%)

Returns from CalciMedica, Inc. Common Stock Stock

-₹66,857 (-66.86%)

Dollar Impact

₹4,071 (+4.07%)

Analyst Recommendation on CalciMedica, Inc. Common Stock Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for CalciMedica, Inc. Common Stock. Average target price of $10.33

CalciMedica, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on CalciMedica, Inc. Common Stock.

What analysts predicted

94.39%UPSIDE

Target Price

$10.33

Current Price

$0.58

Analyzed by

10 Analysts

Target

$10.33

CalciMedica, Inc. Common Stock target price $10.33, a slight upside of 94.39% compared to current price of $0.58. According to 10 analysts rating.

CalciMedica, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for CalciMedica, Inc. Common Stock Stock has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 3, 2026 to May 3, 2026

Change:-73% versus previous 30 day period

CalciMedica, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	0	-	-	-	-
Gross Profit	0	-	0	0	0	0	0	-	-	0
Operating Income	-4	-4	-5	-6	-5	-6	-6	-6	-5	-4
EBITDA	-4	0	0	-3	-5	-4	-4	-5	-7	-4
Interest Expense	-	-	-	-	-	-	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-4	0	-3	-5	-4	-5	-5	-7	-10
Income Tax Expense	0	3	0	-	-	0	-	-	-	-
Net Income	-4	-4	0	-3	-5	-4	-5	-5	-7	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-7096.67%	0.00%	0.00%	0.00%	0.00%

CalciMedica, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-37	-29	-35	-14	-38	-24	-23
EBITDA	-36	-29	-35	-7	-38	-24	-23
Interest Expense	-	0	0	0	0	-	1
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-37	-27	-35	-7	-34	-13	-29
Income Tax Expense	0	0	-1	2	0	-	-
Net Income	-37	-27	-35	-7	-34	-13	-29
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

CalciMedica, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-4	0	-3	-5	-4	-5	-5	-7	-10
Operating Cash Flow	-3	-4	-6	-4	-4	-4	-6	-4	-4
Investing Cash Flow	-	-13	5	8	-5	-1	0	3	7
Financing Cash Flow	0	19	0	0	8	10	0	0	3
Change in Cash	-6	1	-1	4	-1	4	-6	0	6

CalciMedica, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-37	-27	-35	-7	-34	-13	-29
Operating Cash Flow	-31	-32	-31	-11	-25	-21	-21
Investing Cash Flow	-20	-42	10	0	8	-4	9
Financing Cash Flow	54	92	0	8	20	27	15
Change in Cash	3	17	-20	-3	4	2	3

Insights on CalciMedica, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, CalciMedica Inc has experienced a drawdown of -83.5%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 70.8%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 82.2%
NEGATIVE IMPACT
Price Dip
In the last 6 months, CALC stock has moved down by -80.3%

About CalciMedica, Inc. Common Stock

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Organisation	CalciMedica, Inc. Common Stock
Headquarters	505 Coast Boulevard South, La Jolla, CA, United States, 92037
Industry	Biotechnology
CEO	Dr. A. Rachel Leheny Ph.D.
E-voting on shares	Click here to vote

Key Management of CalciMedica, Inc. Common Stock

Name	Title
Mr. Michael J. Dunn B.A., M.B.A.	President & COO
Dr. Stefan Feske M.D.	Co-Founder and Scientific Advisor
Dr. Kenneth A. Stauderman Ph.D.	Co-Founder & Chief Scientific Officer
Dr. A. Rachel Leheny Ph.D.	CEO & Director
Dr. Sudarshan Hebbar M.D.	Chief Medical Officer
Dr. Patrick Hogan Ph.D.	Co-Founder and Scientific Advisor
Mr. Stephen B. Bardin	Chief Financial Officer
Mr. John M. Dunn J.D.	General Counsel
Mr. Eric W. Roberts	Chief Business Officer & Vice Chairman of the Board
Dr. Anjana Rao Ph.D.	Co-Founder and Scientific Advisor

FAQs

What is CalciMedica, Inc. Common Stock share price today?

CalciMedica, Inc. Common Stock share price today is $0.58 as on May 2, 2026 at 1:29 am IST at the close of the market. CalciMedica, Inc. Common Stock share today touched a day high of $0.62 and a low of $0.57.

What is the 52 week high and 52 week low for CalciMedica, Inc. Common Stock share?

CalciMedica, Inc. Common Stock share touched a 52 week high of $7.2 on January 2, 2026 and a 52 week low of $0.46 on March 2, 2026. CalciMedica, Inc. Common Stock stock price today i.e. May 2, 2026 at 1:29 am IST is closed at $0.58,which is 91.94% down from its 52 week high and 25.92% up from its 52 week low.

What is CalciMedica, Inc. Common Stock's market capitalisation today?

CalciMedica, Inc. Common Stock market capitalisation is $0.00T as on May 2, 2026 at 1:29 am IST.

How to invest in CalciMedica, Inc. Common Stock Stock (CALC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for CalciMedica, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CalciMedica, Inc. Common Stock Shares that will get you 2.5862 shares as per CalciMedica, Inc. Common Stock share price of $0.58 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy CalciMedica, Inc. Common Stock Stock (CALC) from India?

Indian investors can start investing in CalciMedica, Inc. Common Stock (CALC) shares with as little as ₹94.91 or $1 (as of May 3, 2026 at 8:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in CalciMedica, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on May 3, 2026 at 8:39 pm IST). Based on CalciMedica, Inc. Common Stock share’s latest price of $0.58 as on May 2, 2026 at 1:29 am IST, you will get 17.2414 shares of CalciMedica, Inc. Common Stock. Learn more about fractional shares .